Your browser doesn't support javascript.
loading
The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cancer - A prospective, controlled, single-center study.
Bolliger, Michael; Lanmüller, Pia; Schuetz, Michael; Heilig, Bernhard; Windischbauer, Amadeus; Jakesz, Raimund; Zehetgruber, Tanja; Gnant, Michael; Gleiss, Andreas; Dörfler, Daniela; Singer, Christian; Bartsch, Rupert; Haslik, Werner; Montagna, Giacomo; Fitzal, Florian.
Afiliación
  • Bolliger M; Department of Surgery, Medical University of Vienna, Austria; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. Electronic address: michael.bolliger@meduniwien.ac.at.
  • Lanmüller P; Department of Surgery, Medical University of Vienna, Austria. Electronic address: lanmueller@dhzb.de.
  • Schuetz M; Department of Surgery, Medical University of Vienna, Austria. Electronic address: michael.schuetz@kl.ac.at.
  • Heilig B; Department of Surgery, Medical University of Vienna, Austria. Electronic address: bernhard.heilig@gesundheitsverbund.at.
  • Windischbauer A; Department of Surgery, Medical University of Vienna, Austria. Electronic address: amadeus.windischbauer@ordensklinikum.at.
  • Jakesz R; Department of Surgery, Medical University of Vienna, Austria. Electronic address: raimund.jakesz@meduniwien.ac.at.
  • Zehetgruber T; Department of Surgery, Medical University of Vienna, Austria. Electronic address: tanja.zehetgruber@ordensklinikum.at.
  • Gnant M; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. Electronic address: michael.gnant@meduniwien.ac.at.
  • Gleiss A; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria. Electronic address: andreas.gleiss@meduniwien.ac.at.
  • Dörfler D; Department of Gynecology, Medical University of Vienna, Vienna, Austria. Electronic address: daniela.doerfler@meduniwien.ac.at.
  • Singer C; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria; Department of Gynecology, Medical University of Vienna, Vienna, Austria. Electronic address: christian.singer@meduniwien.ac.at.
  • Bartsch R; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. Electronic address: rupert.bartsch@meduniwien.ac.at.
  • Haslik W; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria; Department of Gynecology, Medical University of Vienna, Vienna, Austria. Electronic address: werner.haslik@meduniwien.ac.at.
  • Montagna G; Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: monttagng@mskcc.org.
  • Fitzal F; Department of Surgery, Medical University of Vienna, Austria; Breast Health Center, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria. Electronic address: florian.fitzal@meduniwien.ac.at.
Int J Surg ; 104: 106694, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35662621
ABSTRACT

INTRODUCTION:

Oncoplastic techniques allow resection of larger tumors, permitting breast conservation in cases otherwise requiring mastectomy. We sought to prospectively compare quality of life (QoL) in patients undergoing oncoplastic surgery as compared to conventional breast conservation (CBC) or mastectomy is lacking.

METHODS:

Patients diagnosed with BIRADS IV-VI lesion were eligible if resection of ≥10% of the breast volume was planned. Patients were allowed to decide whether they wanted to undergo CBC or oncoplastic breast conservation (OBC). Patients who underwent mastectomy and immediate breast reconstruction (IBR) were also included for comparison. The primary endpoint was breast self-esteem using the Breast Image Scale (BIS) at 12 months, secondary endpoints were perioperative morbidity and QoL using the BREAST-Q questionnaire.

RESULTS:

From 2011 to 2016, 205 patients were included in the study. 116 patients (56.6%) received CBC, 46 (22.4%) OBC and 43 (21%) MIBR. Women in the OBC group were more likely to have tumors ≥ 2 cm than those in the CBC group (34.7% vs. 17.5%, respectively). Women who underwent MIBR were more likely to have tumors > 5 cm than those in the CBC and OBC groups (23% vs 1% and 10%, respectively). The BIS and BREAST-Q improved in each group after 12 months but did not differ significantly between groups at any time point. Surgical complications (seroma, bleeding, infection, necrosis) were numerically more likely in the OBC and MIBR groups.

CONCLUSION:

OBC and the MIBR allow for resection of larger tumors with a similar quality of life as CBC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Mastectomía Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Int J Surg Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Neoplasias de la Mama / Mastectomía Tipo de estudio: Observational_studies Aspecto: Patient_preference Límite: Female / Humans Idioma: En Revista: Int J Surg Año: 2022 Tipo del documento: Article
...